EFFECTIVENESS OF 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPV-23) IN THE PREVENTION OF HOSPITALIZATIONS DUE TO VACCINE-TYPE PNEUMOCOCCAL PNEUMONIA (ID 811)
Session Name
Vaccines - Impact of Vaccine programs and Serotype Replacement
Presenter
Julio Ramirez, United States of America
Authors
Julio Ramirez, United States of America
Stephen Furmanek, United States of America
Senen Pena, United States of America
William Mattingly, United States of America
Forest Arnold, United States of America
Tim Wiemken, United States of America
Ruth Carrico, United States of America
The Louisville Pneumonia Study Group, United States of America